Last week the
Journal of the American Medical Association (JAMA) published a meta-analysis
documenting that being “overweight was associated with significantly lower
all-cause mortality.” (here).
The study was authored by Dr. Katherine Flegal of the U.S. Centers for
Disease Control and Prevention (CDC) and colleagues at the National Cancer
Institute and the University of Ottawa.
This post
will focus on the study’s scientific findings and the reaction to same, which
is not dissimilar to the research and backlash surrounding tobacco harm
reduction.
Dr. Flegal
and colleagues conducted an extensive search for population studies reporting
all-cause mortality according to categories of the body mass index (BMI), which
is weight in kilograms divided by height in meters squared. They used the following standard categories:
Table 1. BMI Ranges for Weight Categories in the Flegal Meta-Analysis | |
---|---|
BMI Range | Weight Category |
Under 18.5 | Underweight |
18.5 to less than 25 | Normal |
25 to less than 30 | Overweight |
30 to less than 35 | Grade 1 Obesity |
35 to less than 40 | Grade 2 Obesity |
40+ | Grade 3 Obesity |
Dr. Flegal’s
literature search initially identified 7,036 articles, of which 97 met the
criteria for their study, which included adequate adjustment for age, gender
and smoking. The results were reported
as hazard ratios (HRs), which are similar to relative risks.
Table 2. Hazard Ratios (HRs) for All-Cause Mortality According to Weight Categories in the Flegal Meta-Analysis | |
---|---|
Weight Category | HR (95% Confidence Interval) |
Underweight | Not Reported |
Normal Weight | Referent Group |
Overweight | 0.94 (0.91 – 0.96) |
Grade 1 Obesity | 0.95 (0.88 – 1.01) |
Grade 2-3 Obesity | 1.29 (1.18 – 1.41) |
All Obesity | 1.18 (1.12 – 1.25) |
The major
finding is remarkable: Overweight people had a LOWER risk of mortality than
people of normal weight. In addition, Grade
1 obesity (up to BMI < 35) was also associated with lower mortality risk,
although this was not statistically significant.
The results
run counter to the dominant public health message that overweight and obesity
are killers, which is why the study was immediately denounced by many. As Christopher Snowdon pointed out (here), extensive media coverage of the
attacks gave credence to the notion that the analysis was flawed and unreliable. Walter Willett, professor of public health at
Harvard, declared: “This study is really a pile of rubbish and no one should
waste their time reading it.” (here).
This high-profile
assault is similar to that which has been waged against tobacco harm reduction
findings over a 20-year period. In the 1990’s,
Philip Cole and I published numerous scientific articles on the gaping
difference in health risks associated with smokeless tobacco use and
smoking. We were sometimes ignored and
often reviled; ad hominem attacks routinely obscured our important findings.
I have long
had a professional interest in population studies of weight and health. In 2004,
I published the first and only study showing that Swedish men who quit smoking
by switching to snus avoided the weight gain usually seen with smoking cessation
(abstract here).
My research experience provides some insights into the Flegal/CDC study.
Why are
overweight people at less risk of dying than those of normal weight? It’s possible that the normal-weight group included
people who had lost weight because they were ill and were close to death,
thereby raising the death rate in the reference group to which all other
categories were compared. In other
words, an artificially higher death rate in the normal-weight group resulted in
an artificially lower rate among overweights.
Although this is one of the more common criticisms discussed in the media,
it is not likely to be a major factor, because the vast majority of the normal-weight
population are healthy.
A more
likely explanation for Dr. Flegal’s surprising result is that many in her
“overweight” population belong in a properly defined “normal” weight category.
In my weight
research I had to establish BMI categories.
A literature review revealed that major health organizations had changed
the definition of overweight. Up to the
late 1990s, researchers had defined overweight as a BMI of 27+, which meant
that normal weight went from 18.5 up to 27.
Dr. Flegal agreed with this definition, as she published a study using
this classification in 1994 (here).
For reasons
that I was never able to pin down, the definition of overweight changed in the
late 1990s to a BMI of 25+. Suddenly, people
with a BMI from 25 to 27, who were previously normal weight, were now
overweight. The prevalence of overweight
skyrocketed.
Since the
newly-classified overweights continued to die at normal-weight rates, this
reclassification might help explain Dr. Flegal’s finding of low mortality in
the overweight category.
One
unresolved problem with Dr. Flegal’s analysis is that she defined three
distinct obesity categories (1, 2 and 3 in Table 1), but then combined the
mortality results for the highest two categories, and failed to report any
results for the underweight category.
These are important omissions which Dr. Flegal needs to explain.
Despite
these issues, CDC scientists should be commended for publishing this profoundly
important finding: Compared with normal-weight individuals, overweight and
slightly obese people have LOWER mortality.
It’s a shame that their colleagues at the CDC Office of Smoking and
Health aren’t equally forthcoming about the minuscule risks for smokeless
tobacco use. For example, the first
entry on the smokeless tobacco fact sheet from the CDC (available here) is - inexplicably – a webpage for
gutka, a southeast Asian tobacco product that is rarely used in the U.S. The rest of the CDC document conflates
information regarding the health risks from smokeless tobacco use with those
from smoking.
Like tobacco
use, overweight and obesity are the objects of revulsion among some health advocates. Scientific evidence, however, clearly shows
that overweight or minimally obese people have lower mortality risks than those
of normal weight, placing them at risk only for misguided, unscientific public
health interventions like fat taxes (here) or soda restrictions (here).
Like tobacco users, the overweight and obese deserve health policies
based on scientific facts, not fanaticism.
2 comments:
I have to wonder whether pharmaceutical companies had any influence in lowering the standards for "overweight" and "obesity." The same thing has happened with the "normal" designations for blood glucose and total cholesterol. Since the drug companies have pills that affect these measures, it's more profits for them is the number of people designated as "abnormal" grows larger.
My mother had a BMI of 30 or 31 and she lived to be 88 years old.
BMI measurements do not account for muscle mass, lean body mass, fat mass or hour-to-hour fluctuations in body weight.
This study [finding an inverse association between obesity and mortality] is scientifically worthless.
Post a Comment